Zook Heather N, Quijano Janine C, Ortiz Jose A, Donohue Cecile, Erdem Neslihan, Ku Hsun Teresa
Department of Translational Research and Cellular Therapeutics, Arthur Riggs Diabetes and Metabolism Research Institute, City of Hope, Duarte, CA 91010, USA.
Department of Translational Research and Cellular Therapeutics, Arthur Riggs Diabetes and Metabolism Research Institute, City of Hope, Duarte, CA 91010, USA.
STAR Protoc. 2025 Jun 20;6(2):103847. doi: 10.1016/j.xpro.2025.103847. Epub 2025 May 26.
Primary human ductal progenitor-like cells derived from donated pancreas have the potential to serve as a source of therapeutic insulin-producing beta cells for the treatment of diabetes. Here, we present a protocol for studying ductal progenitor-like cells using a good manufacturing practice (GMP)-compatible 3D suspension culture system and a methylcellulose- and Matrigel-based 3D colony assay. We describe steps for dispersing and cryopreserving human pancreatic cells and initiating and maintaining cultures. We then detail how to prepare ductal spheroids or colonies for downstream applications. For complete details on the use and execution of this protocol, please refer to Zook et al. and Quijano et al..
源自捐赠胰腺的原代人导管样祖细胞有潜力成为治疗糖尿病的胰岛素分泌β细胞的治疗来源。在此,我们展示了一种使用符合药品生产质量管理规范(GMP)的3D悬浮培养系统以及基于甲基纤维素和基质胶的3D集落测定法来研究导管样祖细胞的方案。我们描述了分散和冷冻保存人胰腺细胞以及启动和维持培养的步骤。然后,我们详细说明了如何为下游应用制备导管球体或集落。有关本方案使用和执行的完整详细信息,请参考佐克等人以及基哈诺等人的研究。